Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Lentinula edodes mycelia, commonly known as shiitake mushroom mycelium, has been studied for its potential in supporting individuals with wasting conditions, particularly in the context of chronic illnesses such as cancer or HIV/AIDS. The scientific rationale for its use is primarily based on its immunomodulatory and nutritional properties. Shiitake mycelia are rich in beta-glucans, especially lentinan, which has demonstrated immune-enhancing effects in preclinical and some clinical studies. Lentinan has been shown to stimulate macrophages and T-cells, potentially improving host resistance to infections and supporting overall vitality. Several clinical studies in Japan and China have investigated lentinan as an adjunct therapy in cancer patients, where it appeared to improve quality of life and, in some cases, reduce the rate of body mass loss (cachexia). However, these benefits are often modest, and evidence is not uniformly robust. Animal studies suggest shiitake extracts may help mitigate muscle wasting by reducing inflammation and modulating gut microbiota, but human data are limited. Despite some promising findings, the overall quality of evidence is moderate at best, often limited by small sample sizes or lack of rigorous controls. Thus, while there is a scientific basis for considering Lentinula edodes mycelia in the support of wasting conditions, especially due to its immune and nutritional effects, more high-quality clinical trials are needed to confirm efficacy and establish standardized doses.

More about Lentinula edodes mycelia
More about Wasting

Other ingredients used for Wasting

Other health conditions supported by Lentinula edodes mycelia

Products containing Lentinula edodes mycelia